FDA Drugs recall ·
Wegovy (semaglutide) injection, 2.4 mg/0.75 mL… recall
- Recall number
- D-0393-2025
- Date
- (initiated April 9, 2025)
- Company / brand
- Cardinal Health Inc.
7000 Cardinal Pl, Dublin, OH, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 48 Cartons
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.
Why was it recalled?
Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot PZFDE06, Exp 08/31/2025
Distribution
NC, SC, VA
States: North Carolina South Carolina Virginia
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0393-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.